Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    1840703 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Vaccine Treatment of Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: 117-126:Fibroblast growth factor 5 (FGF-5);   Drug: Fibroblast growth factor 5 (FGF-5):172-176/217-220;   Other: IL-2
2 Active, not recruiting Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
Condition: Melanoma
Interventions: Drug: cyclophosphamide;   Biological: Mature dendritic cell vaccine

Study has passed its completion date and status has not been verified in more than two years.